Pericapsular Exparel for Pain Relief in Bunionectomy and Related Procedures
Status:
Terminated
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
Exparel is an FDA-approved local anesthetic (bupivacaine), in a long-release formulation. In
this study the investigators plan to determine the ability of Exparel to control
post-operative pain in common first metatarsophalangeal (MTP) joint procedures (bunion
surgery, 1st MTP fusion, and cheilectomy).